RIGL

Biotechnology LLY RIGL Uncategorized

Rigel Pharma slides as falling contract revenue to drive contraction

Mar 4, 2026

Avalon Capital Research BCRX Biotechnology RIGL Uncategorized XFOR

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Mar 3, 2026